The investigators are doing this research study to see if tocilizumab (Actemra) is safe and effective when used for severe or refractory non-infectious uveitis. Uveitis is an inflammation of the eye that is caused by the body's immune system reacting against the eye tissues.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01603355?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
